Drugs / Silver Fluoride
Trials 2 · a red edge is where a trial was stopped
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 2/31 trial | ||||||
| Phase 2/3 | NCT04804423 | Jan 2020 → Mar 2021 | dental caries, dentin sensitivity | University Medicine Greifswald | Completed | No outcome recorded |
| Phase 31 trial | ||||||
| Phase 3 | NCT07658690 | Sep 2026 → Sep 2027 expected | dentin caries | University of Malaya | Not yet recruiting | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 2 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Silver Fluoride | ClinicalTrials.gov intervention name — accepted as the source's own label NCT07658690 ↗ |
| Known as | Riva Star Aqua | “38% Silver Fluoride (Riva Star Aqua)” NCT07658690 ↗ |
| Route | Topical | “Topical application of 38% silver fluoride will be apply onto dentinal caries lesions using a micro-brush at baseline and 3 months follow up.” NCT07658690 ↗ |